BioCurate Project awarded subsidy by the National Drug Discovery Centre
Author
Date
BioCurate
February 14, 2020
We are pleased to announce Dr Lorna Mitchell, Director of Small Molecule Therapeutics at BioCurate, has been named one of the four recipients of an Australian Government subsidy supporting screening activities at the National Drug Discovery Centre (NDDC).
Dr Lorna Mitchell is leading a BioCurate and Monash University team to investigate new medicines for the treatment of blood cancers including Burkitt’s lymphoma (BL), diffuse large B-cell lymphoma (DLBCL) and multiple myeloma (MM).
The NDDC provides researchers in Australia with access to the latest in advanced robotic high-throughput screening to ensure patients will benefit from novel treatments sooner.
The subsidy covers 90 per cent of the cost of using the NDDC, reducing the cost of a traditional screening campaign – normally upwards of $300,000 – to around $30,000-$45,000.
Congratulations to Dr Lorna Mitchell and the project team for this latest accomplishment.
Find out more about the four projects awarded subsidies.
Visit the National Drug Discovery Centre website for more information.
Return to News
